Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir Add-on in HSV+ Early Course Schizophrenia
NCT00514449Phase 2Completed
- Start
- Jun 2007
- Primary completion
- Sep 2016
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia and schizoaffective disorder comparing Valacyclovir with Placebo (2 arms). Primary endpoints: Positive and Negative Syndrome Scale for Schizophrenia at 18 weeks and Cognitive Function Neuropsychological Battery (Gur Battery) at 18 weeks. Started Jun 2007; status: completed.
02
Drugs
valaciclovir
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00514449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514449.